Newamsterdam Pharma Company N.V. - (NAMS)'s 30-day implied volatility (IV30) was 59.7% at the close on November 10, 2026, up from 53.9% the day before, against a 52-week range of 31.4% to 111.2%. Its 20-day historical volatility was 62.0%.
Data as of November 10, 2026.